While suicide ideation (SI) and depression is common among individuals suffering from Chronic Obstructive Pulmonary Disease (COPD), emerging research has also discovered women with the condition disproportionately experience SI and it persists despite undergoing mental health treatment.
This systematic review and meta-analysis hope to determine the influence of non-steroidal anti-inflammatory agent use on depressive symptoms and in those with depression.
The symptoms of depression were reduced in mice models which had high levels of PGC-1a1 in their skeletal muscle.
Thyroid dysfunction causes many well-recognized changes at the level of the brain, and most are reversible with treatment. Patients who have hypothyroidism often have other neuropsychiatric comorbidities, including affective disorders, depression, cognitive function loss, anxiety, or irritability.
Treatment failure can be caused by a variety of factors, including misdiagnosis of the primary psychiatric complaint, the presence of one or more comorbid conditions, and nonadherence to medication plans.
How can clinicians help veterans with PTSD deal with depression and anxiety symptoms, and process intense feelings of shame and guilt stemming from actions and situations they experienced while serving?
Treatment-resistant cases of trigeminal neuralgia may be treated with duloxetine, according to a new case study.
Even a "magic bullet" leaves a wound that requires a period of recovery.
Disproven medical theories and practices can be slow to change, and nowhere is this truer than in the field of clinical nutrition.
Recent research published in The Journal of Clinical Psychiatry has verified anecdotal evidence of a genetic link to compulsive gambling and found the disorder is associated with several psychiatric conditions.
The brains of hyperglycemic patients with Type 1 diabetes produce elevated levels of the neurotransmitter glutamate, which may increase their risk of depression.
Contrary to popular belief, patients who are prescribed antidepressants experience only minimal weight gain within 12 months of treatment.
Concussions that do not heal within 7-10-days may be associated with psychiatric disorders.
Women treated for depression with collaborative care showed fewer symptoms after treatment than women who received traditional care, according to a new study.
Patients with mental health disorders are significantly more likely to have used or currently use electronic cigarettes.
Study results presented at the 2014 annual meeting of the American Psychiatric Association show that a reduced dosage of the antidepressant vilazodone is as effective as the currently approved dosage.
Study results presented at the 2014 APA annual meeting show patients treated with vortioxetine significant improvement in composite cognition scores compared to patients treated with placebo, independent of the drug's effect on their depression symptoms.
Results from a six-week study show patients with major depressive disorder treated with brexpiprazole had significantly reduced risk of akathisia and other side effects.
When encouraging and supporting patients to quit smoking, varenicline is unlikely to increase the risk of neuropsychiatric adverse events such as suicide, depression, and aggression, even in patients with pre-existing psychiatric illness.
Several factors should be considered when choosing a medication and dosing schedule for this depressed adult male who reports being "very sensitive" to medication and expresses particular concern about being either sedated or "revved up" from an antidepressant.
In addition to treating episodes of major depression, Brintellix (vortioxentine) has demonstrated superiority to placebo on measures of cognitive function in adult patients with major depressive disorder (MDD).
Results from animal models of depression and a human clinical trial show that enhancing, instead of blocking, the NMDA glutamate receptor can cause antidepressant-like effects.
One treatment-resistant depression patient's response to over-the-counter cough medicine led Steven P. Levine, MD, to study the mechanism and effects of dextromethorphan in depression.
Steven P. Levine, MD, recommends selecting a biologic intervention from column A and a psychotherapy agent from column B to effectively treat depression and anxiety.
Sorting through and demystifying the toolkit of antidepressants, anxiolytics, and other psychiatric medications available to hospital physicians.
